Clinical TrialsENSPRYNG Signals a Breakthrough for Roche in MOGAD ENSPRYNG Signals a Breakthrough for Roche in MOGAD Read Post »
Regulatory & Health PolicyNICE Greenlights Zanidatamab for Previously Treated Biliary Tract Cancer NICE Greenlights Zanidatamab for Previously Treated Biliary Tract Cancer Read Post »
New Drug ApprovalMerck’s IDVYNSO™ Approved for Treatment Switch in Virologically Suppres... Merck’s IDVYNSO™ Approved for Treatment Switch in Virologically Suppres... Read Post »
Health Tidings Mergers & AcquisitionsCompass Pathways Builds the Path to Nationwide COMP360 Delivery with Osmind Compass Pathways Builds the Path to Nationwide COMP360 Delivery with Osmind Read Post »
Clinical TrialsAfter the U.S. Green Light, Denmark Accelerates Enlivex Allocetra’s Path After the U.S. Green Light, Denmark Accelerates Enlivex Allocetra’s Path Read Post »
Health TidingsRegulatory Update Expected for LYTENAVA™ in May Regulatory Update Expected for LYTENAVA™ in May Read Post »
Clinical TrialsMerck, Eisai’s LITESPARK-012 Stumbles at the Finish Line in First-Lin... Merck, Eisai’s LITESPARK-012 Stumbles at the Finish Line in First-Lin... Read Post »
Clinical TrialsAstraZeneca Reports Early Proteinuria Reduction With Ultomiris in IgAN Tria... AstraZeneca Reports Early Proteinuria Reduction With Ultomiris in IgAN Tria... Read Post »
New Drug ApprovalEU Authorizes Moderna’s mCOMBRIAX for Influenza and COVID-19 in Adults 50... EU Authorizes Moderna’s mCOMBRIAX for Influenza and COVID-19 in Adults 50... Read Post »
Health TidingsImmunityBio Launches ANKTIVA in Saudi Arabia for Bladder and Lung Cancer ImmunityBio Launches ANKTIVA in Saudi Arabia for Bladder and Lung Cancer Read Post »
Health TidingsOtsuka Unit Taiho Halts Phase 3 STAR-121 Trial After Futility Analysis Otsuka Unit Taiho Halts Phase 3 STAR-121 Trial After Futility Analysis Read Post »
New Drug ApprovalBlenrep Gains China Approval for Relapsed/Refractory Multiple Myeloma Blenrep Gains China Approval for Relapsed/Refractory Multiple Myeloma Read Post »
Health TidingsLantern Pharma Plans FDA Meeting on HARMONIC Trial Amendments for LP-300 in... Lantern Pharma Plans FDA Meeting on HARMONIC Trial Amendments for LP-300 in... Read Post »
Health TidingsRoche Pushes Gazyva Across the Regulatory Finish Line in SLE Roche Pushes Gazyva Across the Regulatory Finish Line in SLE Read Post »
Clinical TrialsBicycle Therapeutics Highlights Nuzefatide Progress in Pancreatic Cancer Bicycle Therapeutics Highlights Nuzefatide Progress in Pancreatic Cancer Read Post »
Clinical TrialsLundbeck Highlights Brain Fog Improvements with Eptinezumab Lundbeck Highlights Brain Fog Improvements with Eptinezumab Read Post »
Clinical TrialsAstraZeneca Reports Positive MIRANDA Trial Results for Tozorakimab in COPD AstraZeneca Reports Positive MIRANDA Trial Results for Tozorakimab in COPD Read Post »
Health TidingsFDA Priority Review Granted to KEYTRUDA Combinations in MIBC Based on Phase... FDA Priority Review Granted to KEYTRUDA Combinations in MIBC Based on Phase... Read Post »
Health TidingsDose Mix-Up Triggers Recall of Ramipril Capsules in UK Dose Mix-Up Triggers Recall of Ramipril Capsules in UK Read Post »
Clinical TrialsNew data from United Therapeutics points to earlier action in pulmonary hyp... New data from United Therapeutics points to earlier action in pulmonary hyp... Read Post »
Clinical TrialsXenon Presents Positive X-TOLE2 Results Supporting Azetukalner in Epilepsy Xenon Presents Positive X-TOLE2 Results Supporting Azetukalner in Epilepsy Read Post »
Health Tidings Mergers & AcquisitionsBiogen Takes Full Control of Felzartamab from TJ Biopharma Biogen Takes Full Control of Felzartamab from TJ Biopharma Read Post »
ManufacturingAskBio Scales Up Production of Ametefgene Parvec to Support Ongoing Phase I... AskBio Scales Up Production of Ametefgene Parvec to Support Ongoing Phase I... Read Post »
Clinical TrialsNovo Nordisk Delivers a New Pulse in Sickle Cell Care with Etavopivat Novo Nordisk Delivers a New Pulse in Sickle Cell Care with Etavopivat Read Post »
Health Tidings Mergers & AcquisitionsEli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion, Advancing I... Eli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion, Advancing I... Read Post »
GenericsANI Pharmaceuticals Rolls Out Generic Pimozide, Gains 180-Day Edge ANI Pharmaceuticals Rolls Out Generic Pimozide, Gains 180-Day Edge Read Post »
Health TidingsPasithea Therapeutics Secures FDA Rare Pediatric Disease Designation for NF... Pasithea Therapeutics Secures FDA Rare Pediatric Disease Designation for NF... Read Post »
GenericsAlembic, Aurobindo Secure USFDA ANDA Approvals Alembic, Aurobindo Secure USFDA ANDA Approvals Read Post »
Health Tidings Regulatory & Health PolicyFederal Order Expands Access and Research for Psychedelic Therapies Federal Order Expands Access and Research for Psychedelic Therapies Read Post »
ResearchZai Lab Highlights Long-Lasting Reduction in Pruritus and Inflammation with... Zai Lab Highlights Long-Lasting Reduction in Pruritus and Inflammation with... Read Post »
ResearchWhat Is the Optimal Time to Take Statins: Morning or Evening? What Is the Optimal Time to Take Statins: Morning or Evening? Read Post »
Clinical TrialsSanofi’s COVID-19 Vaccine Nuvaxovid Demonstrates Superior Tolerability vs... Sanofi’s COVID-19 Vaccine Nuvaxovid Demonstrates Superior Tolerability vs... Read Post »
Clinical TrialsModerna’s mRNA-4359 Opens a New Front in the Fight Against Advanced Melan... Moderna’s mRNA-4359 Opens a New Front in the Fight Against Advanced Melan... Read Post »
Health TidingsVYVGART Opens New Doors Across MG Subtypes and Steps Earlier Into CIDP VYVGART Opens New Doors Across MG Subtypes and Steps Earlier Into CIDP Read Post »
Health Tidings Mergers & AcquisitionsUCB Seeks to Rebuild Brain Balance with $1.15B Neurona Move UCB Seeks to Rebuild Brain Balance with $1.15B Neurona Move Read Post »
New Drug ApprovalShifting the Treatment Ground: NICE Endorses Oral Pirtobrutinib for CLL Shifting the Treatment Ground: NICE Endorses Oral Pirtobrutinib for CLL Read Post »
Clinical TrialsZai Lab’s Zocilurtatug Pelitecan Shows Strong Intracranial Responses in E... Zai Lab’s Zocilurtatug Pelitecan Shows Strong Intracranial Responses in E... Read Post »
Clinical TrialsNuvalent’s Zidesamtinib Demonstrates Strong Activity in Pretreated ROS1+ ... Nuvalent’s Zidesamtinib Demonstrates Strong Activity in Pretreated ROS1+ ... Read Post »
Clinical TrialsGigaGen Reports Early Phase 1 Data for GIGA-564 in Advanced Solid Tumors at... GigaGen Reports Early Phase 1 Data for GIGA-564 in Advanced Solid Tumors at... Read Post »
Health Tidings Mergers & AcquisitionsGilead Sciences, Inc. Clears Final Hurdles, Locks in Arcellx, Inc. Deal Gilead Sciences, Inc. Clears Final Hurdles, Locks in Arcellx, Inc. Deal Read Post »
Clinical TrialsRoche advances Elevidys with planned Phase III study to support EMA resubmi... Roche advances Elevidys with planned Phase III study to support EMA resubmi... Read Post »
Health Tidings Mergers & AcquisitionsVir Biotechnology Closes Astellas Deal to Advance VIR-5500 in Prostate Canc... Vir Biotechnology Closes Astellas Deal to Advance VIR-5500 in Prostate Canc... Read Post »
New Drug ApprovalEC Approves ENFLONSIA for RSV Prevention in Infants Across Europe EC Approves ENFLONSIA for RSV Prevention in Infants Across Europe Read Post »
Mergers & AcquisitionsAligos and Amoytop Enter Strategic Licensing Pact for HBV Therapy in Greate... Aligos and Amoytop Enter Strategic Licensing Pact for HBV Therapy in Greate... Read Post »
New Drug ApprovalNICE Backs Belantamab Mafodotin for Relapsed Multiple Myeloma in NHS NICE Backs Belantamab Mafodotin for Relapsed Multiple Myeloma in NHS Read Post »
Clinical TrialsLilly Bolsters Foundayo’s Case with ACHIEVE-4 Data Under FDA Scrutiny Lilly Bolsters Foundayo’s Case with ACHIEVE-4 Data Under FDA Scrutiny Read Post »
Regulatory & Health PolicyFDA Lays the Groundwork for Expanding Testosterone Therapy’s Reach FDA Lays the Groundwork for Expanding Testosterone Therapy’s Reach Read Post »
Mergers & AcquisitionsMeiraGTx Takes the Lead on Bota-vec, Driving Toward Regulatory Approval in ... MeiraGTx Takes the Lead on Bota-vec, Driving Toward Regulatory Approval in ... Read Post »
Clinical TrialsTurning the Tap Back On: MeiraGTx’s AAV-hAQP1 Delivers Three-Year Durabil... Turning the Tap Back On: MeiraGTx’s AAV-hAQP1 Delivers Three-Year Durabil... Read Post »
Clinical TrialsBayer Advances a Safer Clot Strategy as Asundexian Lowers Stroke Risk by 26... Bayer Advances a Safer Clot Strategy as Asundexian Lowers Stroke Risk by 26... Read Post »
